Your browser doesn't support javascript.
loading
Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer.
Zhao, Jinlu; Mei, Jie; Wang, Fengxu; Zhao, Xinyuan; Ren, Yi; Zhao, Xingyu; Li, Wang; Gao, Erli.
Afiliación
  • Zhao J; Department of General Surgery, Τhe Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
  • Mei J; Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.
  • Wang F; Wuxi College of Clinical Medicine, Nanjing Medical University, Wuxi 214023, China.
  • Zhao X; Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong 226019, China.
  • Ren Y; Department of Occupational Medicine and Environmental Toxicology, Nantong Key Laboratory of Environmental Toxicology, School of Public Health, Nantong University, Nantong 226019, China.
  • Zhao X; Department of General Surgery, Τhe Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
  • Li W; Department of General Surgery, Τhe Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
  • Gao E; Department of General Surgery, Τhe Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
J Oncol ; 2022: 1469354, 2022.
Article en En | MEDLINE | ID: mdl-36090897

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Oncol Año: 2022 Tipo del documento: Article País de afiliación: China